1. Home
  2. VYGR vs XWIN Comparison

VYGR vs XWIN Comparison

Compare VYGR & XWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.96

Market Cap

236.0M

Sector

Health Care

ML Signal

HOLD

XWIN

XMAX Inc.

N/A

Current Price

$7.21

Market Cap

386.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
VYGR
XWIN
Founded
2013
2003
Country
United States
United States
Employees
N/A
27
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
236.0M
386.0M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
VYGR
XWIN
Price
$3.96
$7.21
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$16.50
N/A
AVG Volume (30 Days)
568.4K
1.1M
Earning Date
05-05-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,135,000.00
N/A
Revenue This Year
$34.04
N/A
Revenue Next Year
$7.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.65
$5.20
52 Week High
$5.55
$7.42

Technical Indicators

Market Signals
Indicator
VYGR
XWIN
Relative Strength Index (RSI) 49.83 64.87
Support Level $3.72 $5.58
Resistance Level $4.30 $7.42
Average True Range (ATR) 0.20 0.15
MACD 0.00 -0.03
Stochastic Oscillator 60.42 41.54

Price Performance

Historical Comparison
VYGR
XWIN

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

About XWIN XMAX Inc.

XMax Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.

Share on Social Networks: